73 related articles for article (PubMed ID: 3691628)
1. Human monoclonal immunoglobulins that bind the human acetylcholine receptor.
Eng H; Lefvert AK; Mellstedt H; Osterborg A
Eur J Immunol; 1987 Dec; 17(12):1867-9. PubMed ID: 3691628
[TBL] [Abstract][Full Text] [Related]
2. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
Graus YF; de Baets MH; Parren PW; Berrih-Aknin S; Wokke J; van Breda Vriesman PJ; Burton DR
J Immunol; 1997 Feb; 158(4):1919-29. PubMed ID: 9029134
[TBL] [Abstract][Full Text] [Related]
3. Suppression of antibody responses to the acetylcholine receptor by natural antibodies.
Sundblad A; Hauser S; Holmberg D; Cazenave PA; Coutinho A
Eur J Immunol; 1989 Aug; 19(8):1425-30. PubMed ID: 2776827
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
Agius MA; Geannopoulos CJ; Fairclough RH; Richman DP
J Immunol; 1988 Jan; 140(1):62-8. PubMed ID: 3257231
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling of the complex between Torpedo acetylcholine receptor and anti-MIR Fab198.
Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E
Biochem Biophys Res Commun; 2007 May; 356(3):569-75. PubMed ID: 17376405
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
Tzartos SJ
In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
[TBL] [Abstract][Full Text] [Related]
8. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
9. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor.
Loutrari H; Kokla A; Tzartos SJ
Eur J Immunol; 1992 Sep; 22(9):2449-52. PubMed ID: 1516631
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
Kawanami S; Tsuji R; Oda K
Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
[TBL] [Abstract][Full Text] [Related]
12. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
Gomez CM; Richman DP
J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
[TBL] [Abstract][Full Text] [Related]
13. Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules.
Sterz R; Hohlfeld R; Rajki K; Kaul M; Heininger K; Peper K; Toyka KV
Muscle Nerve; 1986 May; 9(4):306-12. PubMed ID: 2423869
[TBL] [Abstract][Full Text] [Related]
14. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
Zoda T; Yeh TM; Krolick KA
J Immunol; 1991 Jan; 146(2):663-70. PubMed ID: 1987281
[TBL] [Abstract][Full Text] [Related]
15. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
Agius MA; Richman DP
J Immunol; 1986 Oct; 137(7):2195-8. PubMed ID: 3489757
[TBL] [Abstract][Full Text] [Related]
16. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
Tzartos SJ; Sophianos D; Efthimiadis A
J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
[TBL] [Abstract][Full Text] [Related]
17. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
[TBL] [Abstract][Full Text] [Related]
18. Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin.
Morel E; Vernet-der Garabedian B; Raimond F; Audhya TK; Goldstein G; Bach JF
Eur J Immunol; 1987 Aug; 17(8):1109-13. PubMed ID: 3622601
[TBL] [Abstract][Full Text] [Related]
19. High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor.
Tsantili P; Tzartos SJ; Mamalaki A
J Neuroimmunol; 1999 Feb; 94(1-2):15-27. PubMed ID: 10376932
[TBL] [Abstract][Full Text] [Related]
20. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
